Alstrom Syndrome Europe
09113143
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/07/2025
micro entity
Next accounts due
30/04/2027
Confirmation statement
Last: 02/07/2025
Due 16/07/2026
Industry
Officers
director · Since 10/01/2016
PROF BIOCHEMISTRY & MOLECULAR BIOLOGY
SPANISH · SPAIN · Age 59
Professor Diana Valverde Perez
director · Since 10/01/2016
PROF BIOCHEMISTRY & MOLECULAR BIOLOGY
SPANISH · SPAIN · Age 59
director · Since 01/07/2024
CHIEF EXECUTIVE
BRITISH · ENGLAND · Age 48
Also on 1 other board
Dr Tarekegn Geberhiwot
director · Since 20/07/2026
BRITISH,EGYPTIAN · ENGLAND · Age 62
Former
Dr Tarekegn Geberhiwot
director · Resigned 16/07/2026
director · Resigned 16/07/2026
director · Resigned 16/07/2026
CompanyRankvs 40755+ SIC 86900 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2025
Net Worth
£3k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£3k
Working capital
Current Assets
£3k
Current Liabilities
—
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | — | +£0 |
| 2024 | Infinity | +£0 |
Derived from filed accounts. Not audited figures.